Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy
出版年份 2022 全文链接
标题
Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-05-26
DOI
10.3389/fphar.2022.907108
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Patient Survival Between Hemodialysis and Peritoneal Dialysis Among End-Stage Renal Disease Patients Secondary to Myeloperoxidase-ANCA-Associated Vasculitis
- (2022) Xueqin Wu et al. Frontiers in Medicine
- Efficacy and safety of tacrolimus combined with corticosteroids in patients with idiopathic membranous nephropathy: a systematic review and meta-analysis of randomized controlled trials
- (2022) Zhonghua Tian et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Salivary microbiota analysis of patients with membranous nephropathy
- (2022) Shaodong Luan et al. Molecular Medicine Reports
- Anti-PLA2R antibody measured by ELISA predicts the risk of vein thrombosis in patients with primary membranous nephropathy
- (2022) Huizi Zhu et al. RENAL FAILURE
- TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
- (2022) Xiao-Yong Yu et al. Frontiers in Pharmacology
- Integrated Fecal Microbiome and Serum Metabolomics Analysis Reveals Abnormal Changes in Rats with Immunoglobulin A Nephropathy and the Intervention Effect of Zhen Wu Tang
- (2021) Jicheng Li et al. Frontiers in Pharmacology
- Rituximab in Membranous Nephropathy
- (2021) Philipp Gauckler et al. Kidney International Reports
- Natural products: potential treatments for cisplatin-induced nephrotoxicity
- (2021) Chun-yan Fang et al. ACTA PHARMACOLOGICA SINICA
- Recurrent membranous nephropathy after transplantation: donor antigen and HLA converge in defining risk
- (2021) Kate J. Robson et al. KIDNEY INTERNATIONAL
- A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in China
- (2021) Lianzhong Wu et al. MEDICAL SCIENCE MONITOR
- Tangshen Formula Attenuates Diabetic Kidney Injury by Imparting Anti-pyroptotic Effects via the TXNIP-NLRP3-GSDMD Axis
- (2021) Nan Li et al. Frontiers in Pharmacology
- Advances in Membranous Nephropathy
- (2021) Pierre Ronco et al. Journal of Clinical Medicine
- The challenges and opportunities of traditional Chinese medicines against COVID-19: a way out from a network perspective
- (2021) Hua-li Zuo et al. ACTA PHARMACOLOGICA SINICA
- Perspectives in membranous nephropathy
- (2021) Nicola M. Tomas et al. CELL AND TISSUE RESEARCH
- Traditional Chinese Medicine as an adjunct therapy in the treatment of idiopathic membranous nephropathy: A systematic review and meta-analysis
- (2021) Zhenzhen Lu et al. PLoS One
- Yiqi Jiedu Huayu Decoction Alleviates Renal Injury in Rats With Diabetic Nephropathy by Promoting Autophagy
- (2021) Chen Xuan et al. Frontiers in Pharmacology
- Astragaloside II Ameliorated Podocyte Injury and Mitochondrial Dysfunction in Streptozotocin-Induced Diabetic Rats
- (2021) Jun Su et al. Frontiers in Pharmacology
- Herbal Medicine “Shulifenxiao” Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy
- (2021) Hailan Cui et al. Frontiers in Pharmacology
- Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy
- (2021) Vladimir Tesar et al. Frontiers in Immunology
- Membranous Nephropathy: From Research Bench to Personalized Care
- (2021) Barbara Moszczuk et al. Journal of Clinical Medicine
- Mechanisms of Primary Membranous Nephropathy
- (2021) Yan Gu et al. Biomolecules
- Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort
- (2021) Shuang Gao et al. Frontiers in Medicine
- Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy
- (2021) Anne-Els van de Logt et al. Kidney International Reports
- Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease
- (2021) Xue-qi Liu et al. ACTA PHARMACOLOGICA SINICA
- Antiphospholipase A2 receptor antibody‐positive membranous nephropathy in the kidney donor: Lessons from a serendipitous transplantation
- (2021) Alicia Molina Andújar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Comparison of 3 anti-PLA2R inmmunoassaysfor the diagnosis of idiopathic membranous nephropathy in an european population. A pilot study
- (2021) Israel Nieto-Gañán et al. CLINICAL IMMUNOLOGY
- Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
- (2021) Shan-Shan Li et al. Frontiers in Pharmacology
- Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review
- (2021) Zhi-Hua Yang et al. Frontiers in Pharmacology
- A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy
- (2021) Pingna Zhang et al. Journal of Immunology Research
- Clinical Phenotypes and Predictors of Remission in Primary Membranous Nephropathy
- (2021) Roxana Jurubiță et al. Journal of Clinical Medicine
- M2 Macrophage Subpopulations in Glomeruli Are Associated With the Deposition of IgG Subclasses and Complements in Primary Membranous Nephropathy
- (2021) Wenxue Hu et al. Frontiers in Medicine
- Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity
- (2021) Jia-yi He et al. ACTA PHARMACOLOGICA SINICA
- 1‐Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway
- (2021) Hua Miao et al. BRITISH JOURNAL OF PHARMACOLOGY
- Recurrent Glomerular Disease after Kidney Transplantation
- (2021) Audrey Uffing et al. Clinical Journal of the American Society of Nephrology
- Traditional Uses, Pharmacological Effects, and Molecular Mechanisms of Licorice in Potential Therapy of COVID-19
- (2021) Qian-hui Zhang et al. Frontiers in Pharmacology
- Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways
- (2021) Liang-Pu Luo et al. Frontiers in Pharmacology
- Signaling Potential Therapeutic Herbal Medicine Prescription for Treating COVID-19 by Collaborative Filtering
- (2021) Fan Yang et al. Frontiers in Pharmacology
- Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources
- (2021) Rajeev K. Singla et al. Frontiers in Pharmacology
- Case Report: Homozygous Pathogenic Variant P209L in the TTC21B Gene: A Rare Cause of End Stage Renal Disease and Biliary Cirrhosis Requiring Combined Liver-Kidney Transplantation. A Case Report and Literature Review
- (2021) Giuseppe Gambino et al. Frontiers in Medicine
- Changes of Brain Functional Connectivity in End-Stage Renal Disease Patients Receiving Peritoneal Dialysis Without Cognitive Decline
- (2021) Ting-Yu Chang et al. Frontiers in Medicine
- Ganoderic acid A is the effective ingredient of Ganoderma triterpenes in retarding renal cyst development in polycystic kidney disease
- (2020) Jia Meng et al. ACTA PHARMACOLOGICA SINICA
- Membranous Nephropathy in Pregnancy
- (2020) Zi-ning Liu et al. AMERICAN JOURNAL OF NEPHROLOGY
- Tripterygium wilfordii multiglycosides combined with prednisone in the treatment of idiopathic membranous nephropathy
- (2020) Yuxia Jin et al. MEDICINE
- Comparison of the efficacy and safety of tacrolimus monotherapy and cyclophosphamide combined with glucocorticoid in the treatment of adult primary membranous nephropathy: protocol of a multicenter, randomized, controlled, open study
- (2020) Shasha Chen et al. Trials
- A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology : Reproducibility of natural product research
- (2020) Angelo A. Izzo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Identification of endogenous 1‐aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation
- (2020) Hua Miao et al. BRITISH JOURNAL OF PHARMACOLOGY
- Wenyang Lishui Decoction Ameliorates Podocyte Injury in Membranous Nephropathy Rat and Cell Models by Regulating p53 and Bcl-2
- (2020) Huan Lu et al. Evidence-based Complementary and Alternative Medicine
- Advances of the experimental models of idiopathic membranous nephropathy (Review)
- (2020) Han Jiang et al. Molecular Medicine Reports
- The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis
- (2020) Jingyuan Xie et al. Nature Communications
- Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway
- (2020) Zhi-quan Chen et al. ACTA PHARMACOLOGICA SINICA
- Single-nucleotide polymorphism rs4664308 in PLA2R1 gene is associated with the risk of idiopathic membranous nephropathy: a meta-analysis
- (2020) Masahiro Yoshikawa et al. Scientific Reports
- How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?
- (2020) Zhendong Feng et al. Frontiers in Pharmacology
- Zhen-Wu-Tang Protects IgA Nephropathy in Rats by Regulating Exosomes to Inhibit NF-κB/NLRP3 Pathway
- (2020) Honglian Li et al. Frontiers in Pharmacology
- Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial
- (2020) Vesna Brglez et al. Frontiers in Medicine
- Advances in Pathogenesis of Idiopathic Membranous Nephropathy
- (2020) Zhifeng Xu et al. Kidney Diseases
- Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome
- (2020) Jun Zhang et al. MICROBIAL PATHOGENESIS
- A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy
- (2020) Ruijuan Dong et al. Frontiers in Cellular and Infection Microbiology
- Efficacy of Chinese Herbal Injections for the Treatment of Primary Nephrotic Syndrome: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
- (2020) Hangxing Yu et al. Frontiers in Pharmacology
- Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity
- (2020) Wenbin Liu et al. Frontiers in Immunology
- Bu-Shen-Huo-Xue Decoction Ameliorates Diabetic Nephropathy by Inhibiting Rac1/PAK1/p38MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Mice
- (2020) Weisong Wang et al. Frontiers in Pharmacology
- Huidouba Improved Podocyte Injury by Down-Regulating Nox4 Expression in Rats With Diabetic Nephropathy
- (2020) KunBao Yang et al. Frontiers in Pharmacology
- Secondary Membranous Nephropathy. A Narrative Review
- (2020) Gabriella Moroni et al. Frontiers in Medicine
- The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
- (2020) Gema Fernández-Juárez et al. KIDNEY INTERNATIONAL
- Sanqi oral solution ameliorates renal damage and restores podocyte injury in experimental membranous nephropathy via suppression of NFκB
- (2019) Ruimin Tian et al. BIOMEDICINE & PHARMACOTHERAPY
- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
- (2019) Fernando C. Fervenza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Zhen-wu-tang ameliorates membranous nephropathy rats through inhibiting NF-κB pathway and NLRP3 inflammasome
- (2019) Bihao Liu et al. PHYTOMEDICINE
- Membranous Nephropathy (MN) Recurrence After Renal Transplantation
- (2019) Patrizia Passerini et al. Frontiers in Immunology
- Effectiveness and Safety of Cyclophosphamide or Tacrolimus Therapy for Idiopathic Membranous Nephropathy
- (2019) Honghong Zou et al. INTERNAL MEDICINE JOURNAL
- Asiatic acid prevents renal fibrosis in UUO rats via promoting the production of 15d-PGJ2, an endogenous ligand of PPAR-γ
- (2019) Zhi-hao Zhang et al. ACTA PHARMACOLOGICA SINICA
- Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease
- (2019) Qian Wang et al. CLINICA CHIMICA ACTA
- Clinical observation on the effect of Wuzhi soft capsule on FK506 concentration in membranous nephropathy patients
- (2019) Zhu Zhang et al. MEDICINE
- Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways
- (2019) Xiao-qiang Geng et al. ACTA PHARMACOLOGICA SINICA
- Molecular Pathogenesis of Membranous Nephropathy
- (2019) Pierre Ronco et al. Annual Review of Pathology-Mechanisms of Disease
- Response Predictors to Calcineurin Inhibitors in Patients with Primary Membranous Nephropathy
- (2018) Xiaofang Yu et al. AMERICAN JOURNAL OF NEPHROLOGY
- Membranous Nephropathy: Approaches to Treatment
- (2018) Andrew S. Bomback et al. AMERICAN JOURNAL OF NEPHROLOGY
- Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis
- (2018) Ming Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rituximab versus the modified Ponticelli regimen in the treatment of primary membranous nephropathy: a Health Economic Model
- (2018) Patrick Hamilton et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Efficacy of Traditional Chinese Medicine Regimen Jian Pi Qu Shi Formula for Refractory Patients with Idiopathic Membranous Nephropathy: A Retrospective Case-Series Study
- (2018) Bin Shi et al. Evidence-based Complementary and Alternative Medicine
- Natural products for the prevention and treatment of kidney disease
- (2018) Dan-Qian Chen et al. PHYTOMEDICINE
- Natural Products as a Source for Antifibrosis Therapy
- (2018) Dan-Qian Chen et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Down‐regulation of the long non‐coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR‐217–TLR4 pathway
- (2018) Ling‐wei Jin et al. EXPERIMENTAL PHYSIOLOGY
- New Insights into Podocyte Biology in Glomerular Health and Disease
- (2017) Suheir Assady et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab for non-responsive idiopathic membranous nephropathy in a Chinese cohort
- (2017) Xin Wang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Zhen-wu-tang attenuates cationic bovine serum albumin-induced inflammatory response in membranous glomerulonephritis rat through inhibiting AGEs/RAGE/NF-κB pathway activation
- (2016) Junbiao Wu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain–Containing 7A–Specific Antibodies in Membranous Nephropathy
- (2016) Elion Hoxha et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Phospholipase A2 Receptor-Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency
- (2016) S. Bally et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
- (2016) Karine Dahan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Mechanism for Cancer-Associated Membranous Nephropathy
- (2016) Elion Hoxha et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy
- (2015) P. Ruggenenti et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serial monitoring of anti-PLA2R in initial PLA2R-negative patients with primary membranous nephropathy
- (2015) Raja Ramachandran et al. KIDNEY INTERNATIONAL
- Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up
- (2015) Anne-Els van de Logt et al. KIDNEY INTERNATIONAL
- Pathophysiological advances in membranous nephropathy: time for a shift in patient's care
- (2015) Pierre Ronco et al. LANCET
- Phospholipase A2 Receptor Autoantibodies and Clinical Outcome in Patients with Primary Membranous Nephropathy
- (2014) E. Hoxha et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy
- (2014) Nicola M. Tomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Traditional Chinese Medicine (Shenqi Particle) for Patients With Idiopathic Membranous Nephropathy: A Multicenter Randomized Controlled Clinical Trial
- (2013) Yiping Chen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
- (2013) Paul E. Stevens ANNALS OF INTERNAL MEDICINE
- Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy
- (2013) Cornelia Dähnrich et al. CLINICA CHIMICA ACTA
- Membranous nephropathy: not just a disease for adults
- (2013) Rivka Ayalon et al. PEDIATRIC NEPHROLOGY
- Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy
- (2011) E. P. McQuarrie et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- PLA2R Autoantibodies and PLA2R Glomerular Deposits in Membranous Nephropathy
- (2011) Hanna Debiec et al. NEW ENGLAND JOURNAL OF MEDICINE
- Astragaloside IV Attenuates Complement Membranous Attack Complex Induced Podocyte Injury Through the MAPK Pathway
- (2011) Rong Zheng et al. PHYTOTHERAPY RESEARCH
- Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2
- (2010) M. Prunotto et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy
- (2009) Laurence H. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation